The Gamaleya vaccine will be given to doctors and teachers first, followed by a mass vaccination campaign in October.
Publisher’s Note: This story was first published on August 6, 2020 and republished tomorrow due to the launch of the vaccine. It was also edited to include some concerns from the Association of Clinical Trials Organizations
In a race for a vaccine that will protect people from the novel coronavirus, six candidates from around the world are currently in phase three of human trials. According to recent reports from Russia, one of their candidates has successfully completed all three phases of human clinical trials. Russia is reportedly set to start manufacturing the vaccine soon and has plans for a massive nationwide vaccine campaign.
Russia currently has two COVID-1
From August 1st TASS reported that human trials with Gam-COVID-Vac Lyo – the vaccine candidate from the Gamaleya Scientific Research Institute – are now complete. Registration of the vaccine will start as early as August 10th to 12th. The vaccine will then be delivered “within three to seven days of registration” in accordance with a Bloomberg Report.
“Clinical studies with a coronavirus vaccine developed by the Gamaleya Center have been completed. Registration of the vaccine is in preparation,” said Russian Health Minister Mikhail Murashko in the report.
TASS reports that the head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said the people injected with Gam-COVID-Vac Lyo developed immunity on the 21st day after receiving the first dose. He said that after receiving the second injection, her immunity doubled.
“I can tell you that in the first and second phases after day 21, one hundred percent of people develop immunity. After the second shot, it doubles. One hundred percent of the animals were also protected (against the novel coronavirus).” Said Dmitriev.
However, it was not until July 13 that the reports came out with Russia claiming theirs two-part phase I trial What a success.
The World Health Organization was Tracking various COVID-19 candidates and did not mention that the vaccine eliminates all three phases of human trials. Health experts are concerned that Russia is Cut corners and trace quickly the process that endangers people. WHO also stepped in, calling on the country to follow established guidelines to produce a “safe and effective vaccine”.
WHO spokesman Christian Lindmeier said at a press conference“Sometimes individual researchers claim they found something, which is obviously good news. But there is a big difference between finding or knowing whether a vaccine works and going through all stages.” “”
Dr. Anthony Fauci, director of the National Institute for Allergies and Infectious Diseases in the United States warned“I hope the Chinese and Russians actually test the vaccine before they give the vaccine to anyone.”
In a report by BloombergSvetlana Zavidova, the executive director of the Association of Clinical Trials Organizations, said. “Why do all companies obey the rules, but the Russian ones don’t? The rules for conducting clinical trials are written in blood. You cannot be hurt. “
“This is a Pandora’s box and we don’t know what will happen to people who have been injected with an unproven vaccine,” she added.
On August 2, the chief of the Russian sanitary station became Anna Popova said in an interview on the Rossiya-1 TV station: “I have no doubt that the vaccine [against the novel coronavirus] That said, reaching people is completely safe and of course efficient. “
“I would like to hope that [immunity] will be sustainable and permanent, “she added.
The Russian Defense Ministry too came in to clarify that it “tests the vaccine on volunteers in full compliance with applicable laws and scientific methodological prescriptions in order to avoid further risks without attempting to shorten the duration of the research.”
Production of the vaccine should begin
A Reuters A report citing an anonymous source said Russia’s first potential vaccine will be approved by regulators this month. Production of this vaccine is scheduled to begin in September.
Industry and Trade Minister Denis Manturov said in an interview with TASS said: “The Gamaleya Institute is working on series production with three companies with locations in the Vladimir, Yaroslavl and Moscow regions, namely Generium, R-Pharm and Binnopharm. We very much hope that series production will start as early as September.”
Although exact numbers were not given, Manturov said several thousand cans will be produced every month this year. By 2021, Russian companies will produce “several million” doses of the vaccine from the Gamaleya National Research Institute of Epidemiology and Microbiology.
Dmitriev, in an interview with the Rossiya-24 TV Channel said that more than 20 countries from around the world have shown interest in manufacturing the Russian vaccine.
“Our foreign partners are showing great interest in producing this vaccine in their countries. Brazil, India and many other countries have great interest in the Russian vaccine, the world’s first vaccine,” said Dmitriev TASS.
“And now more than five countries are actively working with us to start manufacturing the Russian vaccine,” he added.
Mass vaccination by October
On August 1, Health Minister Murashko said Russia plans to launch a mass vaccination campaign against the novel coronavirus in October. According to a report by LivemintThe vaccine is given to doctors and teachers first.
“We continue planning [vaccination] for October because we have to gradually introduce a new treatment system, “Murashko said, according to a report from TASS.
The vaccine will also be “free” and the cost will be taken from the country’s budget.
The EpiVacCorona vaccine, made by the Vektor State Research Center and the Federal Service for the Supervision of Consumer Rights Protection and Human Wellbeing Biotechnology, recently announced it Start mass production of the vaccine in November.
They had started their experiments on humans on July 24th and only on August 4th, 2020 three out of five volunteers were vaccinated with the fifth volunteer who received the first dose yesterday, August 5th. The age of 18-30 years. The EpiVacCorona doses are re-administered after 21 days.
According to the Federal Service for the Supervision of the Protection of Consumer Rights and Human Well-being, Russia is developing 26 additional candidates for coronavirus vaccines at 17 research institutions. Murashko said that over the next six to eight weeks, developers of two other vaccines will apply for their permission to start clinical trials with volunteers.
Cozy Bear: Everything We Know About the Hackers Allegedly Targeting COVID-19 Vaccine Research
Russia’s COVID-19 vaccine successfully completes first phase of human clinical trials